Brief Mindfulness Practice for Long COVID Syndrome
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a brief mindfulness practice to assist individuals still experiencing symptoms after a COVID-19 infection, often referred to as long COVID. The goal is to determine if this practice can enhance mental well-being and help manage the stress and uncertainty associated with long COVID. Participants will either engage in the mindfulness practice (microdosing of mindfulness) or join a waitlist group. It suits English speakers who continue to experience symptoms such as coughing, loss of smell, brain fog, or mood changes following a mild to moderate COVID-19 infection. Sessions and surveys will occur online over three months. As an unphased trial, this study provides a unique opportunity to explore innovative approaches to managing long COVID symptoms.
Do I have to stop taking my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to ask the trial organizers for more details.
What prior data suggests that this mindfulness practice is safe for people with long COVID?
Research has shown that mindfulness practices are generally safe for most people. Studies on mindfulness for long COVID indicate that participants usually find these practices manageable. These studies have not reported any serious negative effects. Participants often experience benefits such as reduced stress and improved mood, without harmful side effects. This suggests that short mindfulness practices are a safe choice for those dealing with long COVID symptoms.12345
Why are researchers excited about this trial?
Researchers are excited about the microdosing of mindfulness for Long COVID because it offers a non-pharmaceutical approach to managing symptoms. Unlike standard treatments, which often involve medications targeting specific symptoms, mindfulness promotes overall well-being by helping individuals manage stress and improve mental resilience. This technique is unique because it empowers patients to actively participate in their recovery through simple, short, and accessible practices. This approach could potentially provide relief without the side effects associated with medication.
What evidence suggests that this mindfulness practice might be effective for long COVID?
Research shows that mindfulness meditation can help people with long COVID feel less tired and sleep better. Studies have found that meditation might strengthen the immune system and reduce symptoms after a viral infection. Evidence also suggests that neuro-meditation, a type of mindfulness practice, can help with cognitive issues and reduce both physical and mental fatigue. This trial will evaluate the effects of a brief mindfulness practice, specifically microdosing of mindfulness, on improving well-being for those with long COVID.24567
Who Is on the Research Team?
Javier E Lopez, MD
Principal Investigator
University of California, Davis
Are You a Good Fit for This Trial?
This trial is for English-speaking individuals who had mild to moderate COVID-19 over 3 months ago and are now experiencing long COVID symptoms like cough, loss of smell or taste, fever, body aches, brain fog, sleep issues, fatigue or mood changes. Participants must be able to engage in online sessions and surveys for 3 months.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants engage in a brief mindfulness practice to promote well-being
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Microdosing of mindfulness
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of California, Davis
Lead Sponsor